Rocket One Inc. Common Stock (NASDAQ:RKTO) Cut to “Strong Sell” at Wall Street Zen

Wall Street Zen lowered shares of Rocket One Inc. Common Stock (NASDAQ:RKTO) from a sell rating to a strong sell rating in a report issued on Sunday.

Separately, Weiss Ratings lowered shares of Rocket One Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Rocket One Inc. Common Stock presently has an average rating of “Hold” and an average target price of $5.00.

Rocket One Inc. Common Stock Stock Down 0.5%

Shares of Rocket One Inc. Common Stock stock opened at $0.76 on Friday. The company’s fifty day simple moving average is $0.90 and its two-hundred day simple moving average is $0.91. Rocket One Inc. Common Stock has a 12-month low of $0.49 and a 12-month high of $2.45. The firm has a market cap of $17.01 million, a PE ratio of -0.93 and a beta of 0.96.

Rocket One Inc. Common Stock (NASDAQ:RKTO) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.19) EPS for the quarter.

Institutional Trading of Rocket One Inc. Common Stock

Hedge funds and other institutional investors have recently made changes to their positions in the stock. DRW Securities LLC purchased a new position in Rocket One Inc. Common Stock during the fourth quarter valued at $257,000. Geode Capital Management LLC boosted its holdings in Rocket One Inc. Common Stock by 18.0% in the fourth quarter. Geode Capital Management LLC now owns 181,112 shares of the company’s stock worth $179,000 after acquiring an additional 27,577 shares in the last quarter. Citadel Advisors LLC purchased a new stake in shares of Rocket One Inc. Common Stock in the third quarter worth $232,000. Virtu Financial LLC purchased a new stake in shares of Rocket One Inc. Common Stock in the third quarter worth $184,000. Finally, Lido Advisors LLC increased its holdings in shares of Rocket One Inc. Common Stock by 100.0% during the first quarter. Lido Advisors LLC now owns 39,000 shares of the company’s stock valued at $33,000 after acquiring an additional 19,500 shares in the last quarter. Hedge funds and other institutional investors own 7.08% of the company’s stock.

About Rocket One Inc. Common Stock

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.